Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000089

Executive Chairman gave up 12,529 shares (to pay taxes)

  • Executive Chairman acquired 24,983 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BISARO PAUL · Executive Chairman

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-07 Exercise or conversion : show line 1 in the form +24,983 41,983 D
2019-05-07 Shares withheld for taxes : show line 2 in the form −12,529 $13.44 $168,390 29,454 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-05-07 Exercise or conversion : show line 3 in the form Restricted Stock Units −24,983 74,950 D
Loading xslF345X03/wf-form4_155743822355516.xml…